[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Food & Health

prostate cancer drug J&J illustration
Innovative J&J Cancer Drug Shows 69% Tumor Response
Johnson & Johnson (JNJ) said Saturday that JNJ-6143, an experimental oral prostate cancer drug acquired via its $3.05 billion Halda Therapeutics purchase, shrank or eliminated tumors in 69% of measurable cases in an early-stage trial, a result that underscores the deal’s...
biotech consolidation illustration
Roche's Sweeping Growth Outpaces Biotech Rivals
Swiss drugmaker Roche (ROG.S) edged past third-quarter sales expectations on October 22, 2026, with growth...
Nestlé Exceeds Q3 Sales Amid Russia Exit
Nestlé (NESN.S) reported third-quarter organic sales growth that topped analyst forecasts on Thursday, even as the Swiss food giant formally deconsolidated...
AI Revolution Fuels AstraZeneca's $1.5B Pharma Deal
Kroger's AI Shift Cuts Corporate Jobs by 33%
GSK's $800M Investment Fuels Biopharma Reshoring
AstraZeneca Invests $1B in MA R&D Expansion
FDA Approves Juvmo: Parkinson's Treatment Breakthrough
biotech consolidation illustration
Lilly Inks $3.35B Deal with InnoCare for New Drug Paths
1 month ago
Eli Lilly (LLY.N) signed a research collaboration and licensing pact with Beijing-based InnoCare Pharma (688428.SS) worth up to $3.35 billion on Thursday, underscoring Big Pharma’s...
cardiometabolic drug competition illustration
Enicepatide Boosts Roche in Cardio Drug Arena
1 month ago
Roche (ROG.S) said Monday its experimental drug enicepatide meaningfully cut blood-sugar levels and body weight in a clinical trial, sharpening the Swiss drugmaker’s competitive...
biotech consolidation illustration
Pfizer's $2B Vaccine Standoff Eyes Air-Traffic Fees
1 month ago
Pfizer (PFE) is pressing a roughly $2 billion arbitration claim against Poland and Romania over cancelled Covid-19 vaccine orders, an escalating legal fight that has now swept...
hog margin collapse illustration
Smithfield Faces Pork Segment Loss Amid Margin Collapse
1 month ago
Smithfield Foods (SFD.O) shares fell nearly 2% in extended trading on Tuesday after the pork giant said its fresh pork segment will swing to an adjusted operating loss in Q3, a...
biotech consolidation illustration
Novartis Faces Setbacks in Pipeline Tension
1 month ago
A neuromuscular drug candidate acquired through Novartis’s (NVS) $12 billion Avidity Biosciences deal missed its late-stage primary endpoint, compounding a difficult stretch...
MORE NEWS
gilead ouro deal illustration
Ionis Secures FDA Nod for First Alexander Therapy
1 month ago
Brazil infant formula investment illustration
Nestlé Invests Heavily in Brazil Infant Formula Sector
1 month ago
autoimmune push illustration
Novartis Faces CAR-T Challenges in Autoimmune Trials
1 month ago
CATEGORIES
Reading Mode
Loading article...